The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice

This study aimed to investigate the effect of Fuzheng Yiai Decoction (FZYA) on epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) drug resistance in lung adenosquamous carcinoma (ASC). The expression of thyroid transcription factor 1 (TTF1) and p63 in tumor cells was observed by i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianfeng Sun, Danqing Luo, Hui Li, Di Zhang, Yesha Liu, Song Jin, Hong Guo, Chengshi He, Zhipeng Wu
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Canadian Respiratory Journal
Online Access:http://dx.doi.org/10.1155/carj/8827810
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846107068049653760
author Jianfeng Sun
Danqing Luo
Hui Li
Di Zhang
Yesha Liu
Song Jin
Hong Guo
Chengshi He
Zhipeng Wu
author_facet Jianfeng Sun
Danqing Luo
Hui Li
Di Zhang
Yesha Liu
Song Jin
Hong Guo
Chengshi He
Zhipeng Wu
author_sort Jianfeng Sun
collection DOAJ
description This study aimed to investigate the effect of Fuzheng Yiai Decoction (FZYA) on epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) drug resistance in lung adenosquamous carcinoma (ASC). The expression of thyroid transcription factor 1 (TTF1) and p63 in tumor cells was observed by immunofluorescence staining. Meanwhile, 25 nude mice successfully inoculated with the human lung ASC cell line NCI-H596 were randomly divided into five groups, namely, the model, gefitinib, low-, medium-, and high-dose FZYA with gefitinib groups. After four weeks of daily intragastric administration of the various treatments, the tumor weight and volume inhibition rates were calculated. The positive expression rate and protein expression of TTF1 and p63 in mouse tumor tissues were evaluated by immunohistochemistry and western blot assays. The results showed that the adenocarcinoma part and the squamous cell carcinoma part of the lung tissue were not either one or the other, and each had unique biological behavior patterns. In terms of the tumor volume and weight, gefitinib treatment along with FZYA reduced the acquired resistance of EGFR-TKIs in lung ASC, and its inhibitory effect was superior to EGFR-TKI (gefitinib) treatment alone. Moreover, it was discovered that FZYA inhibited the pedigree transformation among cancer subtypes due to EGFR-TKI treatment. In conclusion, the application of FZYA inhibited the pedigree transformation among lung cancer subtypes, thus increasing the tumor inhibitory effect and decreasing the EGFR-TKI drug resistance of tumor cells.
format Article
id doaj-art-7144e99a901a4d618959edc21a9373da
institution Kabale University
issn 1916-7245
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Canadian Respiratory Journal
spelling doaj-art-7144e99a901a4d618959edc21a9373da2024-12-27T00:00:02ZengWileyCanadian Respiratory Journal1916-72452024-01-01202410.1155/carj/8827810The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant MiceJianfeng Sun0Danqing Luo1Hui Li2Di Zhang3Yesha Liu4Song Jin5Hong Guo6Chengshi He7Zhipeng Wu8Department of RehabilitationDepartment of RehabilitationSichuan Acupuncture and Moxibustion SchoolDepartment of RehabilitationDepartment of RehabilitationDepartment of RehabilitationDepartment of RehabilitationSichuan Acupuncture and Moxibustion SchoolDepartment of RehabilitationThis study aimed to investigate the effect of Fuzheng Yiai Decoction (FZYA) on epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) drug resistance in lung adenosquamous carcinoma (ASC). The expression of thyroid transcription factor 1 (TTF1) and p63 in tumor cells was observed by immunofluorescence staining. Meanwhile, 25 nude mice successfully inoculated with the human lung ASC cell line NCI-H596 were randomly divided into five groups, namely, the model, gefitinib, low-, medium-, and high-dose FZYA with gefitinib groups. After four weeks of daily intragastric administration of the various treatments, the tumor weight and volume inhibition rates were calculated. The positive expression rate and protein expression of TTF1 and p63 in mouse tumor tissues were evaluated by immunohistochemistry and western blot assays. The results showed that the adenocarcinoma part and the squamous cell carcinoma part of the lung tissue were not either one or the other, and each had unique biological behavior patterns. In terms of the tumor volume and weight, gefitinib treatment along with FZYA reduced the acquired resistance of EGFR-TKIs in lung ASC, and its inhibitory effect was superior to EGFR-TKI (gefitinib) treatment alone. Moreover, it was discovered that FZYA inhibited the pedigree transformation among cancer subtypes due to EGFR-TKI treatment. In conclusion, the application of FZYA inhibited the pedigree transformation among lung cancer subtypes, thus increasing the tumor inhibitory effect and decreasing the EGFR-TKI drug resistance of tumor cells.http://dx.doi.org/10.1155/carj/8827810
spellingShingle Jianfeng Sun
Danqing Luo
Hui Li
Di Zhang
Yesha Liu
Song Jin
Hong Guo
Chengshi He
Zhipeng Wu
The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
Canadian Respiratory Journal
title The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
title_full The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
title_fullStr The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
title_full_unstemmed The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
title_short The Effect of Fuzheng Yiai Decoction on the Transdifferentiation of Lung Adenocarcinoma in EGFR-TKI-Resistant Mice
title_sort effect of fuzheng yiai decoction on the transdifferentiation of lung adenocarcinoma in egfr tki resistant mice
url http://dx.doi.org/10.1155/carj/8827810
work_keys_str_mv AT jianfengsun theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT danqingluo theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT huili theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT dizhang theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT yeshaliu theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT songjin theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT hongguo theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT chengshihe theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT zhipengwu theeffectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT jianfengsun effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT danqingluo effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT huili effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT dizhang effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT yeshaliu effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT songjin effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT hongguo effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT chengshihe effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice
AT zhipengwu effectoffuzhengyiaidecoctiononthetransdifferentiationoflungadenocarcinomainegfrtkiresistantmice